In the study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and published in Science Immunology, the researchers found that CD4+ T cells, traditionally called ‘helper T cells’ for their role in aiding the activation of other immune cells, are remarkably effective in controlling melanoma.
Viatris plans for Ozempic, Wegovy generics amid lawsuit from Novo Nordisk over Wegovy
Viatris Pharmaceuticals’ applications for generic options for type 2 diabetes drug Ozempic and weight loss drug Wegovy are now under regulatory review, according to the
August 8, 2023